Bioxyne (ASX:BXNDA) Short Interest


ASX:BXNDA Bioxyne Ltd ASX:BXNDA
50 GF Score
Price A$0.95
GF Value A$0.69
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Bioxyne Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:BXNDA vs KHC, GIS: Short Interest Comparison

For the Packaged Foods subindustry, Bioxyne's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioxyne Short Interest vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioxyne's Short Interest distribution charts can be found below:

* The bar in red indicates where Bioxyne's Short Interest falls into.


ASX:BXNDA
50GF Score
Bioxyne Ltd ASX:BXNDA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioxyne (ASX:BXNDA) Overvalued in 2026?

Based on GuruFocus' analysis, Bioxyne stock appears to be overvalued. The current stock price of A$0.95 is trading 37.7% above its estimated GF Value™ of A$0.69. GuruFocus considers Bioxyne to be Significantly Overvalued.

Key valuation signals for ASX:BXNDA:

  • Short Interest:
  • GF Value™: A$0.69 vs. price of A$0.95 (37.7% above fair value)
  • GF Score™: 50/100 with 8 warning signs

No single metric tells the full story. See the ASX:BXNDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioxyne Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments, namely, Pharmaceutical manufacture and wholesale supply (business to business), Manufacture and distribution (wholesale, online, and retail), and Wholesale of patented Probiotics.
50GF Score

Get the complete analysis for ASX:BXNDA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.95
Price
A$0.69
GF Value